Skip to content
DSML.KZ
Publications

Article · Journal of Research in Health Sciences · June 29, 2023

Epidemiological Analysis of HIV/AIDS in Kazakhstan During 2018-2020

Г.Ж. БИЛИБАЕВА, Dinara Ospanova, Anarkhan Nurkerimova, Farida Kussainova, Marat Tukeyev, Moldir Shokybaeva

Ildar FakhradiyevTimur Saliev
Open via DOI

Abstract

Background: The human immunodeficiency virus (HIV) is a severe threat to public health everywhere, including the Central Asian region and Kazakhstan. The aim of the study was to conduct an epidemiological analysis of newly diagnosed cases of HIV infection during 2018-2020. Study Design: A case series study. Methods: A descriptive analysis of national data on registered cases of HIV in Kazakhstan was conducted, and demographic information was collected and studied accordingly. The analysis of the influence of age, period, and cohort was performed using the age-period-cohort method. Results: Based on the results, men prevailed (68.5%) among all cases of HIV infection (n=1235). Sexual transmission during heterosexual contact was higher in females (88.9%, P=0.005), and the number of new cases as a result of homosexual contact was higher in men (23.0%, P=0.087). In addition, the parenteral route of HIV transmission cases prevailed among men (27.5%, P=0.001), and intravenous drug administration was more common among males (27.4%, P=0.01). Moreover, 68.5% of men and 33.2% of women had a low therapy adherence. In men, the risk of HIV prevalence increased after 32.5 years (deviation [Dv]: 0.134, 95% confidence interval [CI]=0.096 to 0.364). At the age of 37.5 years, there was an increase (Dv: 0.852, 95% CI=0.626 to 1.079) in HIV prevalence. However, no peaks were observed in women. Conclusion: Our findings indicated a rise in the prevalence of HIV infection in Kazakhstan. Men aged 37 and older were identified as the risk category. Eventually, inadequate adherence to treatment was observed in HIV/acquired immunodeficiency syndrome patients.

HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskHIV, TB, and STIs EpidemiologyHIV/AIDSHIV prevalencenew HIV cases

More by Ildar Fakhradiyev